Adjuvant docetaxel plus cisplatin in stage I/II non-small cell lung cancer (NSCLC): Preliminary results of a randomized phase II pilot trial of the Central European Cooperative Oncology Group (CECOG)

7297 Background: Adjuvant chemotherapy treatment for early stage NSCLC patients is not yet standard practice. The aim of the present trial is to compare the activity, safety, and quality of life ef...